Veterinary Medicine Information website

Enrotron Flavour 150 mg Tablets for dogs

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Enrotron Flavour 150 mg Tablets for dogs
Active substance:
  • Enrofloxacin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • (ID10) 100 Tablet: unspecified outer container with 1 Blister (Aluminium; Polyvinylchlorid) with 100 Tablet
  • (ID9) 50 Tablet: unspecified outer container with 1 Blister (Aluminium; Polyvinylchlorid) with 50 Tablet
  • (ID8) 30 Tablet: unspecified outer container with 1 Blister (Aluminium; Polyvinylchlorid) with 30 Tablet
  • (ID7) 20 Tablet: unspecified outer container with 1 Blister (Aluminium; Polyvinylchlorid) with 20 Tablet
  • (ID6) 10 Tablet: unspecified outer container with 1 Blister (Aluminium; Polyvinylchlorid) with 10 Tablet
  • (ID5) 100 Tablet: unspecified outer container with 1 Blister (Aluminium; Aluminium) with 100 Tablet
  • (ID4) 50 Tablet: unspecified outer container with 1 Blister (Aluminium; Aluminium) with 50 Tablet
  • (ID3) 30 Tablet: unspecified outer container with 1 Blister (Aluminium; Aluminium) with 30 Tablet
  • (ID2) 20 Tablet: unspecified outer container with 1 Blister (Aluminium; Aluminium) with 20 Tablet
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium; Aluminium) with 10 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2055
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0137/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Luxembourg
  • Netherlands
  • Poland
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (RTF)
Published on: 13/03/2026
Download
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

2401297-paren-20101101.pdf

English (PDF)
Published on: 14/03/2026
Download